Table 2. Comparison of disease variables pre and post the SARS-CoV-2 pandemic.
SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2
| Variable | Pre-COVID-19 | Post-COVID-19 | p-value | |||
| N | % | N | % | |||
| Category of asthma | 0.114 | |||||
| Intermittent | 10 | 9.6 | 5 | 4.8 | ||
| Mild persistent | 27 | 26 | 26 | 25.0 | ||
| Moderate persistent | 64 | 61.5 | 67 | 64.4 | ||
| Severe persistent | 3 | 2.9 | 6 | 5.8 | ||
| Allergic rhinitis | 0.001 | |||||
| Yes | 98 | 94.2 | 85 | 81.7 | ||
| No | 6 | 5.8 | 19 | 18.3 | ||
| Eczema | 0.049 | |||||
| Yes | 28 | 26.9 | 19 | 18.3 | ||
| No | 76 | 73.1 | 85 | 81.7 | ||
| Obstructive sleep apnea | 0.064 | |||||
| Yes | 49 | 47.1 | 39 | 37.5 | ||
| No | 55 | 52.9 | 65 | 62.5 | ||
| Asthmatic biologic agent use | 1.000 | |||||
| Yes | 2 | 1.9 | 3 | 2.9 | ||
| No | 102 | 98.1 | 101 | 97.1 | ||
| Psychiatric disorder | 0.375 | |||||
| Yes | 12 | 11.5 | 15 | 14.4 | ||
| No | 92 | 88.5 | 89 | 85.6 | ||